ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,894Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 546

$402K Total Retail Price of All Prescriptions

Rank: 96 out of 546

312 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 312 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

21% of this provider’s 312 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 4,913 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LEVOTHYROXINE SODIUM 297 234 1 3
HYDROCODONE-ACETAMINOPHEN 294 115 S3 2 8
SIMVASTATIN 283 208 3 2
OMEPRAZOLE 271 155 4 4
OXYCODONE HCL 270 72 S2 5 15
AMLODIPINE BESYLATE 234 187 6 9
LISINOPRIL 209 105 7 1
ATORVASTATIN CALCIUM 202 128 8 11
FUROSEMIDE 189 131 9 5
METFORMIN HCL 169 78 10 10
ATENOLOL 157 99 11 12
METOPROLOL TARTRATE 130 101 12 6
HYDROCHLOROTHIAZIDE 103 85 13 7
PREDNISONE 101 53 14 29
ISOSORBIDE MONONITRATE ER 92 79 15 32
RANITIDINE HCL 92 50 15 23
METOPROLOL SUCCINATE 89 71 17 17
WARFARIN SODIUM 87 70 18 13
KLOR-CON 10 83 70 19 133
ALLOPURINOL 83 59 19 41
ADVAIR DISKUS 79 59 21 20
PROAIR HFA 76 45 22 27
TRAMADOL HCL 75 29 23 19
METFORMIN HCL ER 72 47 24 74
SERTRALINE HCL 71 47 25 14
LOVASTATIN 71 51 25 22
FLUTICASONE PROPIONATE 68 44 27 42
GLIPIZIDE XL 68 30 27 191
ZETIA 66 52 29 81
PAROXETINE HCL 64 17 30 43
ENALAPRIL MALEATE 64 45 30 59
IBUPROFEN 60 18 32 70
GABAPENTIN 56 33 33 16
CYCLOBENZAPRINE HCL 53 0 R 34 34
VENLAFAXINE HCL ER 53 38 34 88
AZITHROMYCIN 53 26 34 55
GLIPIZIDE 50 32 37 44
ALENDRONATE SODIUM 50 49 37 38
CITALOPRAM HBR 50 35 37 21
GEMFIBROZIL 50 21 37 100
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.